Thank you, Mr. Yan and Shelley, and thanks to everyone for joining our call today. As Mr. Yan just mentioned, in Q2, we achieved healthy profitability despite unfavorable market conditions. More excitingly, this is a quarter in which almost all loans were funded by institutional partners, providing very clear evidence that our institutional funding structure is efficient, sustainable and profitable. Our strategy is unchanged. We will generate top line growth by increasing loan origination volume, while optimizing operational cost, improving credit quality and maintaining healthy profitability. Now, let me briefly go over the financial results for the second quarter. Please note that, unless specified otherwise, all financial figures are in RMB. In the interest of time, I will not walk through each item by line on this call. Please refer to our earnings release for more details. I will just highlight some of the key points here. In the second quarter, lower loan volume drove the decline in our top line metrics, as you would expect, given the market condition and our stringent risk policies. Net revenue for the second quarter was RMB245 million, down 61.5% from the same period of 2019. Going forward, we’re ready to resume the growth of fundings. And funding is now all from institutions. Moving to costs. The cost reduction efforts we initiated this year are bearing fruit. You can see this in our much lower operating expenses this quarter. Total operating expenses were RMB197 million, down 24.9% sequentially. This brought us a healthy operating margin of 19.6% versus 16.3% from the prior quarter. We will continue to evaluate ways to optimize our cost structure and further improve our operating efficiency. Origination and servicing expense was RMB50.9 million, down 60.1% year-over-year, primarily due to lower loan origination volume. Allowance for uncollectible receivables and contract assets was RMB10.7 million, down significantly from RMB70.8 million in the same period of 2019. The decrease was primarily due to two factors: first, the lower loan origination volume; and second, our increased efforts in credit assessment and risk management, which optimized our loan performance. General and administrative expense and R&D expense fell to RMB36.6 million and RMB34.1 million, respectively. This was mainly due to the decreased share-based compensation expense allocated to G&A and R&D expenses, as well as the decrease in traveling and other business-related expenses. Sales and marketing expense was RMB64.6 million, down 56.9% year-over-year. This was mainly due to better sales efficiency, a further benefit of satisfying the demand of repeat borrowers. Due to our tight cost control and improved operational efficiency, we were able to sustain healthy profitability. We posted net income of RMB41.1 million, up 4.1% sequentially. Turning to our balance sheet. We ended the quarter with RMB69.9 million in cash and equivalents compared with RMB66.8 million as of March 31, 2020. In summary, as we see recovery in the Chinese consumer economy, we expect loan origination volume in Q3 to be higher than in Q2. With that, let’s open the call for questions. Mr. Yan; Mr. Xu, our Chief Risk Officer; and I will answer questions. Operator, please go ahead.